Zoetis UK Ltd are not making a claim for clinical superiority of CircoMax Myco in the field based on the Bandrick et al 2020 study, which is an immunoinformatic tool (PigMatrix) that integrates algorithms and sequences to predict similarities between putative T-cell epitopes content of a vaccine to field strains and is not an in vivo trial.
If this caused a misunderstanding on that basis, Zoetis apologise.